P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the blood-brain barrier and in several peripheral organs. In order to understand the role of P-gp in physiological and patho-physiological conditions, several carbon-11 labelled P-gp tracers have been developed and validated. This review provides an overview of the spectrum of radiopharmaceuticals that is available for this purpose. A short overview of the physiology of the blood-brain barrier in health and disease is also provided. Tracer kinetic modelling for quantitative analysis of P-gp function and expression is highlighted, and the advantages and disadvantages of the various tracers are discussed
Brain is protected from the molecules circulating in the bloodstream by the blood-brain barrier (BBB...
Increased activity of efflux transporters, e.g., P-glycoprotein (P-gp) and breast cancer resistance ...
Increased activity of efflux transporters, e.g., P-glycoprotein (P-gp) and breast cancer resistance ...
P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the...
P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the...
P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the...
ABC transporters protect the brain by transporting neurotoxic compounds from the brain back into the...
International audienceP-glycoprotein (P-gp) is a major efflux transporter at the blood-brain barrier...
P-glycoprotein is an important transporter belonging to ATP-Binding Cassette pumps (ABC-B1). This tr...
ABC transporters at the human blood-brain barrier protect the brain against the entry of harmful com...
ABC transporters at the human blood-brain barrier protect the brain against the entry of harmful com...
The P-glycoprotein (P-gp) transporter located at the blood-brain barrier (BBB) is an efflux transpor...
ABC transporters at the human blood-brain barrier protect the brain against the entry of harmful com...
The blood-brain barrier (BBB) is the main barrier between blood and brain. Its purpose is to maintai...
ABC transporters protect the brain by transporting neurotoxic compounds from the brain back into the...
Brain is protected from the molecules circulating in the bloodstream by the blood-brain barrier (BBB...
Increased activity of efflux transporters, e.g., P-glycoprotein (P-gp) and breast cancer resistance ...
Increased activity of efflux transporters, e.g., P-glycoprotein (P-gp) and breast cancer resistance ...
P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the...
P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the...
P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the...
ABC transporters protect the brain by transporting neurotoxic compounds from the brain back into the...
International audienceP-glycoprotein (P-gp) is a major efflux transporter at the blood-brain barrier...
P-glycoprotein is an important transporter belonging to ATP-Binding Cassette pumps (ABC-B1). This tr...
ABC transporters at the human blood-brain barrier protect the brain against the entry of harmful com...
ABC transporters at the human blood-brain barrier protect the brain against the entry of harmful com...
The P-glycoprotein (P-gp) transporter located at the blood-brain barrier (BBB) is an efflux transpor...
ABC transporters at the human blood-brain barrier protect the brain against the entry of harmful com...
The blood-brain barrier (BBB) is the main barrier between blood and brain. Its purpose is to maintai...
ABC transporters protect the brain by transporting neurotoxic compounds from the brain back into the...
Brain is protected from the molecules circulating in the bloodstream by the blood-brain barrier (BBB...
Increased activity of efflux transporters, e.g., P-glycoprotein (P-gp) and breast cancer resistance ...
Increased activity of efflux transporters, e.g., P-glycoprotein (P-gp) and breast cancer resistance ...